As therapeutic digital health tools develop at an increasing pace, it is important that they are clinically effective and offer economic value.
A working group led by NHS England, and including National Institute for Health and Care Excellence (NICE), MedCity, Public Health England, and DigitalHealth.London, has developed a framework - set to launch in December 2018 - to address and streamline support on this issue.
The project’s aim is to make it easier for innovators and commissioners to understand what ‘good’ evidence for digital tools looks like, whilst meeting the needs of the NHS and patients. Developing technologies is a collaborative process and key parties have come together, including innovators, commissioners and other stakeholders, to understand everyone’s needs and experiences.
NICE has developed the Evidence Standards Framework for Digital Health Technologies, that has two parts, describing:
- Evidence for effectiveness for intended use, and;
- Evidence for economic impact.
The Framework is set to launch in December 2018, and it will:
- Enable better NHS commissioning, with commissioners being better equipped to know what questions to ask developers about their evidence generation plans and what to expect back;
- Support digital health innovators and clinical innovators with how the NHS makes decisions and the standards of evidence expected from them;
- Facilitate a dynamic, value driven market, setting clear standards to help the development of high quality health products that can be more easily adopted and integrated into the health system
For more information please speak with the EFE Working Group at firstname.lastname@example.org
What does this mean for you?
Find out who is involved in the project, how it came about, and what is in it for companies and commissioners by clicking below.
You can also view a presentation with a preview of the draft framework
How to get involved
Developing the NICE Evidence Standards Framework for Digital Health Technologies has been a collaborative process, requiring input from innovators, commissioners and other stakeholders. Over the past five months we have invited you to contribute your thoughts and help design the framework at our workshops. Your input has been crucial in helping industry better understand the evidence they need to generate and in helping commissioners identify the evidence they should be looking for.
We have worked with commissioners, industry, academics, clinicians, accelerators, and others, to look at the clinical effectiveness and economic impact of innovations.
NICE is set to launch the Framework in December and we will be sharing it via our newsletter – you can sign up here: http://eepurl.com/bUwJDr
If you have any questions or comments, please get in touch with Neelam Patel, MedCity, at email@example.com
Take a look at the events where we will be exhibiting or presenting on the project, and come along to meet us face to face.
5 – 6 September: NHS Expo – NICE and NHS England (Stand & presentation)
11 – 12 September: Public Health England’s Annual Conference – PHE and NICE (Stand)
13 September: London Business Conference, Goldsmiths University – Neelam Patel presenting
12 September: Digitalhealth.London’s Accelerator Cohort 3 launch – DigitalHealth.London and MedCity
12 – 14 September: Guidelines International Network (G-I-N) Conference – NICE (Stand)
24 – 26 September: The MedTech Conference – Neelam Patel presenting
25 September: UK Health Show – NHS England and NICE (Stand and presentation)
4 – 6 October: RCGP Conference – NICE (stand)
9 – 10 October: NHS Providers Conference – NICE (stand)
25 October: Angels in MedCity Company Showcase – MedCity presenting
6 November: Clinical Entrepreneur Programme 2019 – Indra speaking
8 November: Genomics England’s Discovery Forum – Neelam Patel presenting
13-14 November: HSJ Summit – NHS England (Stand and presentation)
20 – 21 November: Acute and General Medicine Conference – NICE (Stand)
21 November: GIANT Health Event – DigitalHealth.London & MedCity Evidence stream
News and Blogs